Author(s):
Deepalakshmi M, Ajay Samraj P, Diya C, Jonna Venkatesh, Kamalrathinam R S, Arun K P
Email(s):
kparun@jssuni.edu.in
DOI:
10.52711/0974-360X.2021.01027 
Address:
Deepalakshmi M, Ajay Samraj P, Diya C, Jonna Venkatesh, Kamalrathinam R S, Arun K P*
Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 11,
Year - 2021
ABSTRACT:
AIDS is a deadly syndrome in which Highly Active Anti-retroviral therapy is used to reduce the viral load. However these anti-retroviral drugs are supposed to cause several adverse drug reaction. There are several studies that report anemia with Zidovudine and gastrointestinal symptoms with Lamivudine. In this report, We present a case of a 38 year old female patient suffering from HIV infection who is suspected to drug induced anemia and gastritis due to Zidovudine, Lamivudine and Nevirapine combination (ZLN) regimen. The relationship between the administered drug regimen and the suspected ADR’s was found using causality assessment. Severity, predictability and probability was also found for the suspected ADR’s. We need to monitor the HIV patients who are under ZLN regimen for their blood haemoglobin and gastrointestinal symptoms.
Cite this article:
Deepalakshmi M, Ajay Samraj P, Diya C, Jonna Venkatesh, Kamalrathinam R S, Arun K P. Case Report on Mild Anemia and Gastritis due to Zidovudine, Lamivudine and Nevirapine (ZLN) Regimen. Research Journal of Pharmacy and Technology. 2021; 14(11):5911-2. doi: 10.52711/0974-360X.2021.01027
Cite(Electronic):
Deepalakshmi M, Ajay Samraj P, Diya C, Jonna Venkatesh, Kamalrathinam R S, Arun K P. Case Report on Mild Anemia and Gastritis due to Zidovudine, Lamivudine and Nevirapine (ZLN) Regimen. Research Journal of Pharmacy and Technology. 2021; 14(11):5911-2. doi: 10.52711/0974-360X.2021.01027 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-11-53
REFERENCES:
1. Tamir Z, Alemu J, Tsegaye A. Anemia among HIV infected individuals taking art with and without zidovudine at Addis Ababa, Ethiopia. Ethiopian Journal of Health Sciences. 2018; 28(1):73.
2. Madan Mohan Rao., Rama R., Reddy GA, Samson Deepak., R Rohith., Subbiah M., Vijayan Venugopala., Case report on severe anemia and acute gastritis due to zidovudine, lamivudine, nevirapine (zln) regimen. Reactions Weekly. 2015; 1559(1):101.
3. Maheshwari P, Manju Sunny. A Prospective Study on the Knowledge, Attitude and Perception on HIV/AIDS among the Nursing and other Healthcare Professionals. Research J. Pharm. and Tech 2016; 9(9):1403-1406.
4. Belperio PS, Rhew DC. Prevalence and outcomes of anaemia inindividuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004; 116 (Suppl 7A): 27S-43S.
5. Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A., Janecek E., Domecq C., Greenblatt D.J. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 1981; 30:239–245. doi: 10.1038/clpt.1981.154.
6. Schumock G.T., Thornton J.P. Focusing on the preventability of adverse drug reactions. Hosp. Pharm. 1992; 27:538.
7. Hartwig S.C., Siegel J., Schneider P.J. Preventability and severity assessment in reporting adverse drug reactions. Am. J. Hosp. Pharm. 1992; 49:2229–2232.
8. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anaemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998; 91 : 301-8.
9. Abdullahi Rabiu Abubakar, Nordin Bin Simbak, Mainul Haque. Adverse Drug Reactions: Predisposing Factors, Modern Classifications and Causality Assessment. Research J. Pharm. and Tech. 7(9): 2014;1091-1098.